GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (BSP:I1DX34) » Definitions » Cyclically Adjusted PS Ratio

IDEXX Laboratories (BSP:I1DX34) Cyclically Adjusted PS Ratio : 14.70 (As of May. 13, 2024)


View and export this data going back to 2020. Start your Free Trial

What is IDEXX Laboratories Cyclically Adjusted PS Ratio?

As of today (2024-05-13), IDEXX Laboratories's current share price is R$485.25. IDEXX Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was R$33.02. IDEXX Laboratories's Cyclically Adjusted PS Ratio for today is 14.70.

The historical rank and industry rank for IDEXX Laboratories's Cyclically Adjusted PS Ratio or its related term are showing as below:

BSP:I1DX34' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 5.06   Med: 13.21   Max: 30.79
Current: 15.54

During the past years, IDEXX Laboratories's highest Cyclically Adjusted PS Ratio was 30.79. The lowest was 5.06. And the median was 13.21.

BSP:I1DX34's Cyclically Adjusted PS Ratio is ranked worse than
94.03% of 134 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.325 vs BSP:I1DX34: 15.54

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

IDEXX Laboratories's adjusted revenue per share data for the three months ended in Mar. 2024 was R$11.437. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is R$33.02 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


IDEXX Laboratories Cyclically Adjusted PS Ratio Historical Data

The historical data trend for IDEXX Laboratories's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Cyclically Adjusted PS Ratio Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.41 24.50 27.04 14.34 17.29

IDEXX Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.89 16.39 13.85 17.29 16.46

Competitive Comparison of IDEXX Laboratories's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, IDEXX Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Cyclically Adjusted PS Ratio falls into.



IDEXX Laboratories Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

IDEXX Laboratories's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=485.25/33.02
=14.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEXX Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, IDEXX Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=11.437/129.4194*129.4194
=11.437

Current CPI (Mar. 2024) = 129.4194.

IDEXX Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.684 100.560 2.167
201409 1.779 100.428 2.293
201412 1.920 99.070 2.508
201503 2.516 99.621 3.269
201506 2.728 100.684 3.507
201509 3.415 100.392 4.402
201512 3.379 99.792 4.382
201603 3.400 100.470 4.380
201606 3.518 101.688 4.477
201609 3.201 101.861 4.067
201612 3.278 101.863 4.165
201703 3.211 102.862 4.040
201706 3.732 103.349 4.673
201709 3.453 104.136 4.291
201712 3.745 104.011 4.660
201803 3.964 105.290 4.872
201806 4.944 106.317 6.018
201809 5.067 106.507 6.157
201812 4.859 105.998 5.933
201903 5.054 107.251 6.099
201906 5.458 108.070 6.536
201909 5.689 108.329 6.797
201912 5.695 108.420 6.798
202003 7.059 108.902 8.389
202006 7.657 108.767 9.111
202009 8.992 109.815 10.597
202012 8.528 109.897 10.043
202103 10.084 111.754 11.678
202106 9.588 114.631 10.825
202109 9.891 115.734 11.061
202112 10.516 117.630 11.570
202203 9.731 121.301 10.382
202206 10.238 125.017 10.599
202209 10.494 125.227 10.845
202212 10.370 125.222 10.718
202303 11.169 127.348 11.351
202306 10.907 128.729 10.966
202309 10.766 129.860 10.730
202312 10.526 129.419 10.526
202403 11.437 129.419 11.437

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IDEXX Laboratories  (BSP:I1DX34) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


IDEXX Laboratories Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories (BSP:I1DX34) Business Description

Traded in Other Exchanges
Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

IDEXX Laboratories (BSP:I1DX34) Headlines

No Headlines